Old Web
English
Sign In
Acemap
>
authorDetail
>
Jia Li Low
Jia Li Low
Internal medicine
Medicine
Oncology
Lung cancer
Immunotherapy
6
Papers
29
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Low-dose pembrolizumab in the treatment of advanced non-small cell lung cancer.
2021
International Journal of Cancer
Jia Li Low
Yiqing Huang
Kenneth Sooi
Yvonne. Ang
Zhi Yao Chan
K. Spencer
Anand D. Jeyasekharan
Raghav Sundar
Boon Cher Goh
Ross A. Soo
Wei Peng Yong
Show All
Source
Cite
Save
Citations (1)
Low-Dose Nivolumab in Renal Cell Carcinoma: A Real-World Experience.
2021
Oncology
Joseph Zhao
Nesaretnam Barr Kumarakulasinghe
Vaishnavi Muthu
Matilda Lee
Robert John Walsh
Jia Li Low
Joan Choo
Hon-Lyn Tan
Wan Qin Chong
Yvonne. Ang
Gloria Chan
Wei Peng Yong
Yiqing Huang
Natalie Ngoi
Alvin Wong
Show All
Source
Cite
Save
Citations (1)
Cost and efficacy of low-dose pembrolizumab in the treatment of non-small cell lung cancer patients in Asia.
2020
Journal of Clinical Oncology
Jia Li Low
Kenneth Sooi
Yiqing Huang
Gloria Hj Chan
Yvonne L.E. Ang
Wan Qin Chong
Hon-Lyn Tan
Natalie Ngoi
Joan Choo
Matilda Lee
Vaishnavi Muthu
Yugarajah Asokumaran
Robert John Walsh
Rachel Su Jen Wong
Zhi Yao Chan
Ross A. Soo
Raghav Sundar
Wei Peng Yong
Show All
Source
Cite
Save
Citations (1)
The evolving immuno-oncology landscape in advanced lung cancer: first-line treatment of non-small cell lung cancer:
2019
Therapeutic Advances in Medical Oncology
Jia Li Low
Robert John Walsh
Yvonne L.E. Ang
Gloria Hj Chan
Ross A. Soo
Show All
Source
Cite
Save
Citations (22)
1